Immunogenicity Testing and Antibody Humanization

Antitope is pioneering a new generation of immunogenicity testing, antibody humanization and protein engineering technologies.

Our mission is to apply these technologies to create improved non-immunogenic biologics. Formed in 2004, Antitope provides proprietary technologies as a comprehensive service for the preclinical prediction of clinical immunogenicity,  and for the generation of humanized antibodies, therapeutic proteins and recombinant vaccines. To date, we have entered into multiple agreements with pharmaceutical and biotechnology companies worldwide to apply our technologies for the development of improved biologics.